CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks. Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
PERSONALPROFESSIONALCORPORATE
SUPPORT
en
Trading
Trading
Ways to trade
CFD trading
Professional
Trading platforms
All platforms 
Web platform
Mobile apps
MT4
TradingView
Trading info
Margin Calls
Fraud prevention
Trading tools
CFD calculator
Demo trading
Markets
Markets
Our markets
Shares
Forex
Indices
Commodities
Cryptocurrencies
Market updates
Market analysis
Learn
Learn
For trading beginners
Trading Essentials
Risk management
Market guides
Demo trading
For experienced traders
Trading Strategies
Technical analysis
Market analysis
Trading Psychology
Pricing
Pricing
Pricing
Charges and fees
Our business model
Payments and withdrawals
About
About
About us
Why Capital.com?
Our history
Our offices
Leadership team
Client funds
Contact us
Get help
Help
Client vulnerability
Complaints
Terms and policies
Work for us
Careers
Tech recruitment
My account
PERSONALPROFESSIONALCORPORATE
SUPPORT
en
My account

HomeMarketsSharesAcurx Pharmaceuticals, Inc.

Trade Acurx Pharmaceuticals, Inc. - ACXP CFD

Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.

Latest shares articles

Markets swing as traders re-adjust to trading in Trump’s world
Explore market reactions to Trump's trade policies, including USD drops, oil price shifts, and tariff impacts.
08:15, 21 January 2025
USD/JPY drops below 156 as US CPI eases and BOJ rate hike expectations increase
An increase in rate hike expectations from the BOJ and softer US CPI data see USD/JPY turn lower
14:47, 16 January 2025
UK inflation cools in December, GBP/USD attempts to bounce back
UK inflation drops more than expected in December, easing some of the fears about the UK economy.
09:41, 15 January 2025
Market Analysis: EUR/GBP Extends Rally but Faces Key Resistance
A worsening economic outlook in the UK is driving the pound lower, pushing EUR/GBP to a two-and-a-half-month high.
14:56, 14 January 2025

Read our reviews to find out more about us

Read the feedback from our clients, whatever their experience level.
2024-10-22
infoaamon

Very trustworthy and affordable for any size trades

2024-10-21
remi74

It is very easy to connect with TradingView but the web interface is also great.

2024-10-15
jdancer37

Easy to use and great support. Been using it for 2 years already and still happy

2024-10-14
DANIEL

Capital.com is one of the best stock trading platforms I’ve used. The UX and UI on both the mobile app and web platform are outstanding, making it incredibly easy to navigate. They’ve built a vibrant community of traders and investors, and their UAE team really stands out for delivering an exceptional trading experience.

2024-10-08
Yahyaamez

Best broker!! they call you to see if you need any help. The app is good and nice better than the rest

2024-10-04
Iuliia Salivon

Great app! I requested some features to be added, such as analysis tools, and they delivered. Amazing job! The agents are always helpful and reply quickly. It’s not 5 stars because, at times, some less experienced agents may say it’s impossible to fulfill the request or fix the problem while another agent, like Angel, quickly escalated the issue to the necessary team/person/department and resolved it

2024-10-04
Moh ST

This is an excellent platform. The stop loss and take profit work very well; however, when the changes are very fast like at the beginning of the session, the stop loss does not work. If this defect is corrected it will be the perfect platform.

2024-09-30
adenysenko24

-Nice -Easy to use - Beautiful Interface

2024-09-26
Daniel

I think I'm new in this trading platform, but I find it affordable and most reliable. To be honest I'm not fully experienced trader, but with very limited knowledge of trading I try learn as much as I can by trying out different platforms see if can make money. My interests growing in you platform, l like news updates you also short videos on YouTube, other propaganda, poster and many more. I will see what happens in the coming months. Thanks capital team.

2024-09-26
John Fallows

Gives you options to start learning how too do it as it gives you a demo option to learn from your mistakes

2024-09-24
PHEMELO

Efficiency. When creating the account, it was smooth, efficient from start to finish. Verification of documents also was done the same day, unlike other platforms where you have to wait a day or two.

2024-09-04
Osondu Paul

From what I'm seeing it's cool Mixing it with trading view it's perfect... I didn't give it 5 star yet cos I still need to use it for some time

Showing our 4 & 5 star reviews

4.6
Ratings and Reviews
4.7
Ratings and Reviews
4.5
4.3

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading